The leaves and bark of Lindera fragrans herbs have been conventionally used in Traditional Chinese Medicine (TCM) as qi regulating drugs. This work was aimed to study the chemical constituents, possible antidepressant activity and mechanism of ethanol extract from L. fragrans leaves. In this study, ultra-high performance liquid chromatography (UPLC) coupled with hybrid quadrupole-orbitrap high-resolution mass spectrometry (UPLC-Q-Orbirap HRMS) technology was used to analyze and identify chemical components of the ethanol extract of L. fragrans leaves. In addition, chronic unpredictable mild stress (CUMS) model was established to measure the behavioral indexes of L. fragrans leaves extract on depressed mice, including weight, sucrose preference, tail suspension time, and serum corticosterone (CORT), serotonin (5-HT) and norepinephrine (NE) detected by ELISA. The results indicate that L. fragrans leaves extract contains approximately 22 compounds and can significantly increase the sucrose preference, reduce the tail suspension time, and regulate the levels of CORT, 5-HT and NE in CUMS depressed mice. This research proved for the first time that L. fragrans leaves extract treatment successfully reduced chronic mild stress-induced depressive-like behaviors in mice, as well as CUMS mice hyperactivity on the hypothalamus-pituitary-adrenal (HPA) axis.
Similar content being viewed by others
References
H. König, H. H. König, A. Konnopka, et al., Epidemiol. Psych. Sci., 29(30), 1 – 16 (2019).
Y. Chandrasekhar, E. M. Ramya, K. Navya, et al., Biomed. Pharmacother., 86, 414 – 425 (2017).
P. Willner, J. Scheel-Kruger, C. Belzung, et al., Neurosci. Biobehav. Rev., 37(10), 2331 – 2371 (2013).
H. Chen, Q. Huang, S. Zhang, et al., Nutrients, 11(4), 1 – 14 (2019).
S. Yu, C. Li, Y. Ding, et al., Pharm. Biol., 58(1), 208 – 218 (2020).
M. S. Abbasi and Z. Mousavi., Iran. J. Basic. Med. Sci., 20(9), 1063 – 1073 (2017).
J. Cardenas, V. Reyes-Perez, M. D. Hernandez-Navarro, et al., J. Ethnopharmacol., 200, 22 – 30 (2017).
F. R. Hamann, A. M. Zago, M. F. Rossato, et al., J. Ethnopharmacol., 192, 210 – 216 (2016).
P. Amoateng, K. K. E. Kukuia, J. A. Mensah, et al., Metab. Brain. Dis., 33(4), 1359 – 1368 (2018).
J. E. Donello, P. Banerjee, Y. X. Li, et al., Int. J. Neuropsychopharmacol., 22(3), 247 – 259 (2019).
R. S. Duman, N. Li, R. J. Liu, et al., Neuropharmacology, 62(1), 35 – 41 (2012).
S. Vuckovic, D. Srebro, V. K. Savic, et al., Pharm. Biol., 53, 1621 – 1627 (2015).
A. A. Murtala and A. J. Akindele., J. Ethnopharmacol., 249, 112420 (2020).
H. F. Liu, M. C. Huang, W. F. Du, et al., Chin. J. Trad. Chin. Med. Pharm., 39(8), 171 – 174 (2021).
H.W. Hu, Y. Y. Zhao, T. L. Yang, et al., Chin. J. Exp. Trad. Med. Pharm., 26(7), 148 – 155 (2020).
C. Zhang, Y. P. Zhang, Y. Y. Li, et al., Behav. Brain Res., 356, 348 – 357 (2019).
M. C. Schweizer, M. S. Henniger, I. Sillaber, et al., PLoS One., 4(1), 4326 (2009).
A. Tanti, Brit. J. Pharmacol., 159(6), 1187 – 1200 (2010).
K. Li, L. Yan, Y. Zhang, et al., J. Ethnopharmaco., 250, 112487 (2020).
H. Zhang, Y. Sun, S. Qian, et al., J. Ethnopharmacol., 250, 112380 (2020).
J. Zhu, E. Yuan, J. Y. Mou, et al., Chin. J. Exp. Trad. Med. Form., 26(16), 142 – 153 (2020).
E. Bora, B. J. Harrison, C. G. Davey, et al., Psychol. Med., 42(4), 671 – 681 (2012).
Y. L. Huang, N. X. Zeng, J. Chen, et al., Neur. Regen. Res., 15(6), 1150 – 1159 (2020).
C. F. Ye, Y. H. Cai, Q. P. Zeng, et al., Pharm. Care Res., 20(6), 414 – 417 (2020).
L. Cai, Y. R. Mu, M. M. Liu, et al., Int. J. Immunopharmacol., 80, 106182 (2020).
H. Zhang, Y. Sun, S. Qian, et al., J. Ethnopharmacol., 250, 112380 (2020).
M. D. Zhang, X. Tao, R. L. Pan, et al., Fitoterapia, 141, 104450 (2020).
C. A. Browne, T. Smith, I. Lucki, et al., Eur. J. Pharmacol., 872, 172948 (2020).
J. Su, Y. W. Pan, S. Q. Wang, et al., Int. J. Immunopharmacol., 80, 106181 (2020).
Y. Guo, J. Xie, X. Li, et al., Front. Pharmacol., 9, 1126 (2018).
M. Gill, M. Kinra, A. Rai, et al., Neuroreport, 29, 134 – 140 (2018).
D. Mizuki, K. Matsumoto, K. Tanaka, et al., J. Ethnopharmacol., 156, 16 – 25 (2014).
Z. Huang, X. Huang, Q. Wang, et al., IUBMB Life., 70, 300 – 309 (2018).
J. O. Fajemiroye, K. Adam, K. Z. Jordan, et al., Iran. J. Pharm. Res., 17(2), 613 – 626 (2018).
N. N. Pauleti, J. Mello, D. A. Siebert, et al., Nat. Prod. Res., 32(16), 1987 – 1990 (2018).
A. L. B. Zeni, A. D. E. Zomkowski, M. Maraschin, et al., J. Ethnopharmacol., 148(3), 914 – 920 (2013).
Y. Liu, S. Shen, Z. Li, et al., Neurochem. Int., 78, 43 – 52 (2014).
A. D. E. Zomkowski, D. Engel, M. P. Cunha, et al., Pharmacol. Biochem. Behav., 103(2), 408 – 417 (2012).
D. G. Machado, M. V. S. Lara, P. B. Dobler, et al., Prog. Neuro-Psychopharmacol, Biol. Psychiatry, 98, 109776 (2020).
X. Zhang, Chin. J. Ethnomed. Ethnopharmacol., 24(24), 29 – 30 (2015).
J. Walstab, C. Wohlfarth, R. Hovius, et al., Neurogastroenterol. Motil., 26(6), 810 – 20 (2014).
L. T. Yi, C. F. Li, X. Zhan, et al., Prog. Neuropsychopharmacol. Biol. Psychiatry, 34(7), 1223 – 1228 (2010).
L. T. Yi, J. Li, H. C. Li, et al., Prog. Neuropsychopharmacol. Biol. Psychiatry, 39(1), 175 – 181 (2012).
L. T. Yi, B. B. Liu, J. Li, et al., Prog. Neuropsychopharmacol. Biol. Psychiatry, 48, 135 – 141 (2014).
C. F. Shi, M. Zhang, Y. Li, et al., J. Logist. Univ. Pap. Med. Sci., 27(10), 805 – 809 (2018).
Y. Tang, B. Diao, X. K. Wang, et al., Chin. Med. Mat., 30(12), 1555 – 1558 (2007).
F. F. Rocha, M. T. R. Lima-Landman, C. Souccar, et al., Phytomedicine, 14(6), 396 – 402 (2007).
X. J. Liu, F. X. Wei, H. L. Liu, et al., J. Ethnopharmacol., 268, 113549 (2020).
S. N. Wang, Y. S. Ding, X. J. Ma, et al., Molecules, 23(9), 2329 (2018).
G. L. D. Oliveira, J. C. C. L. da Silva, A. P. D. C. L. da Silva, et al., Curr. Mol. Pharmacol., 14(1), 36 – 51 (2021).
C. C. Qi, Y. M. Shu, F. H. Chen, et al., Behav. Brain Res., 300, 106 – 113 (2016).
CONFLICT OF INTEREST
The authors declare that they have no conflicts of interest
Funding
This work was co-supported by the research project of the National Natural Science Foundation of China (NSFC) (No. 31200256), the Open Project Program of Irradiation Preservation Technology Key Laboratory of Sichuan Province, Sichuan Institute of Atomic Energy (No. FZBC2020002), the Funds of Sichuan Science and Technology Program (2021YFSY0041, 2021YFH0064, 2021ZHFP0032, 2020YJ0222, and 2020YFH0061), the Fund of Science and Technology Agency of Chengdu (2019-YF09 – 00049-SN), the research project of the Administration of Traditional Chinese Medicine of Sichuan (2021MS110), and the Fundamental Research Funds for the Central Universities (2682020ZT85), and the 15th Personalized Experimental Project (GX2021160001).
Author information
Authors and Affiliations
Contributions
Si-Wei Wang: conceptualization, experiment, writing-original draft; Shu-Yu Xu: writing-review and editing; Tian Gan: experiment; Xiao-Bin Zhang and Jia-Hong Li: data curation, visualization; Xing Wang and He-Zhong Jiang: project administration, writing-review and editing, vision and editing of the draft.
Corresponding authors
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, SW., Xu, SY., Gan, T. et al. Chemical Constituents and Antidepressant-Like Activity of the Ethanol Extract of Lindera fragrans Leaves. Pharm Chem J 56, 1358–1368 (2023). https://doi.org/10.1007/s11094-023-02798-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-023-02798-0